Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | MMP10 | P09238 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 6/20 | 0.47 |
| ▸ | HTR2A | P28223 | 5/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.47 |
| ▸ | DRD2 | P14416 | 3/20 | 0.47 |
| ▸ | RORC | P51449 | 10/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 7/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5211487 | 0.98 | MMP3 (0.49) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| Hydrochloric Acid SCHEMBL5211483 | 0.97 | MMP3 (0.48) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| SCHEMBL5208997 | 0.84 | MMP3 (0.40) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| SCHEMBL5213110 | 0.84 | GAA (0.48) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| Hydrochloric Acid SCHEMBL5210814 | 0.83 | MMP3 (0.39) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| Hydrochloric Acid SCHEMBL5208964 | 0.82 | GAA (0.47) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| Hydrochloric Acid SCHEMBL5210809 | 0.81 | MMP3 (0.39) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| SCHEMBL5218102 | 0.81 | DRD2 (0.49) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| Hydrochloric Acid SCHEMBL5208960 | 0.81 | GAA (0.46) | MMP3MMP10HTR2CHTR2AKCNH2 | |
| SCHEMBL5217125 | 0.79 | CA2 (0.46) | MMP3MMP10KCNH2RORCALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1641756-B1 | 4-ARYLSULPHONYLPIPERIDINE DERIVATIVES FOR ANTAGONISM OF THE 5-HT2A RECEPTOR | MERCK SHARP & DOHME (GB) | 2007-04-11 | — | — | EP | disclosed |
| US-20060211735-A1 | 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor | MERCK SHARP & DOHME LTD. (GB) | 2006-09-21 | — | — | US | disclosed |
| EP-1641756-A1 | 4-ARYLSULPHONYLPIPERIDINE DERIVATIVES FOR ANTAGONISM OF THE 5-HT2A RECEPTOR | MERCK SHARP & DOHME LTD. (GB) | 2006-04-05 | — | — | EP | disclosed |
| WO-2004101518-A1 | 4-ARYLSULPHONYLPIPERIDINE DERIVATIVES FOR ANTAGONISM OF THE 5-HT2A RECEPTOR | MERCK SHARP & DOHME LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211735-A1 | 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor | HTR2A, HTR2C, HTR5A | MMP3 2778/4885MMP10 2312/4885HTR2C 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.